To study the fetomaternal outcome of decreased sodium level in the patients of one of the subtypes of hypertensive disorders in pregnancy and its association with the severity of the disorder
Not Applicable
- Conditions
- Health Condition 1: O141- Severe pre-eclampsia
- Registration Number
- CTRI/2021/07/034561
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Pregnant women with the period of gestation between 20 to 40 weeks admitted in labour ward with blood pressure more than or equal to 140/90 mmHg measured on 2 occasions 4 hours apart consenting to be enrolled in study.
2)Age more than or equal to 18 years
3)All patients falling under the ACOG Criteria for severe Preeclampsia
Exclusion Criteria
1)Pregnant women who do not consent for study
2)Women with chronic kidney disease, liver disease, cardiovascular disease, collagen vascular disease, chronic hypertension, diabetes, neoplasm, with major fetal anomaly, endocrine disorders causing electrolyte imbalance, CNS disorders, on steroids /diuretics
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Fetomaternal outcome in preeclamptic patients with severe features presenting with hyponatremia <br/ ><br>2) Association of hyponatremia with the severity of preeclampsiaTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method Proportion of hyponatremia in preeclamptic patients with severe featuresTimepoint: 1 YEAR